- Home
- DNA vs FTHY Comparison
DNA vs FTHY Comparison
Compare DNA & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- FTHY
- Stock Information
- Founded
- DNA 2008
- FTHY 2020
- Country
- DNA United States
- FTHY United States
- Employees
- DNA N/A
- FTHY N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- FTHY Investment Managers
- Sector
- DNA Health Care
- FTHY Finance
- Exchange
- DNA Nasdaq
- FTHY Nasdaq
- Market Cap
- DNA 466.4M
- FTHY 500.1M
- IPO Year
- DNA N/A
- FTHY N/A
- Fundamental
- Price
- DNA $8.57
- FTHY $14.46
- Analyst Decision
- DNA Sell
- FTHY
- Analyst Count
- DNA 3
- FTHY 0
- Target Price
- DNA $9.67
- FTHY N/A
- AVG Volume (30 Days)
- DNA 1.1M
- FTHY 176.7K
- Earning Date
- DNA 08-07-2025
- FTHY 01-01-0001
- Dividend Yield
- DNA N/A
- FTHY 10.93%
- EPS Growth
- DNA N/A
- FTHY N/A
- EPS
- DNA N/A
- FTHY N/A
- Revenue
- DNA $237,417,000.00
- FTHY N/A
- Revenue This Year
- DNA N/A
- FTHY N/A
- Revenue Next Year
- DNA $15.81
- FTHY N/A
- P/E Ratio
- DNA N/A
- FTHY N/A
- Revenue Growth
- DNA 13.76
- FTHY N/A
- 52 Week Low
- DNA $5.00
- FTHY $12.66
- 52 Week High
- DNA $18.40
- FTHY $14.74
- Technical
- Relative Strength Index (RSI)
- DNA 55.25
- FTHY 59.61
- Support Level
- DNA $7.14
- FTHY $14.37
- Resistance Level
- DNA $10.02
- FTHY $14.48
- Average True Range (ATR)
- DNA 0.61
- FTHY 0.09
- MACD
- DNA 0.07
- FTHY -0.00
- Stochastic Oscillator
- DNA 53.53
- FTHY 72.38
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.